FR2081544A1 - Immuno-suppressive antilymphocytic serum and - and derived immunoglobulg - Google Patents

Immuno-suppressive antilymphocytic serum and - and derived immunoglobulg

Info

Publication number
FR2081544A1
FR2081544A1 FR7106440A FR7106440A FR2081544A1 FR 2081544 A1 FR2081544 A1 FR 2081544A1 FR 7106440 A FR7106440 A FR 7106440A FR 7106440 A FR7106440 A FR 7106440A FR 2081544 A1 FR2081544 A1 FR 2081544A1
Authority
FR
France
Prior art keywords
blood
antilymphocytic
mammal
serum
immunoglobulg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7106440A
Other languages
English (en)
French (fr)
Other versions
FR2081544B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB167771A external-priority patent/GB1355961A/en
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2081544A1 publication Critical patent/FR2081544A1/fr
Application granted granted Critical
Publication of FR2081544B1 publication Critical patent/FR2081544B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7106440A 1970-02-27 1971-02-25 Immuno-suppressive antilymphocytic serum and - and derived immunoglobulg Granted FR2081544A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB167771A GB1355961A (en) 1970-02-27 1970-02-27 Preparation of immunosuppressive antilymphocytic serum
GB167771 1971-01-13

Publications (2)

Publication Number Publication Date
FR2081544A1 true FR2081544A1 (en) 1971-12-03
FR2081544B1 FR2081544B1 (enExample) 1975-01-17

Family

ID=26236900

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7106440A Granted FR2081544A1 (en) 1970-02-27 1971-02-25 Immuno-suppressive antilymphocytic serum and - and derived immunoglobulg

Country Status (8)

Country Link
BE (1) BE763573A (enExample)
CA (1) CA970279A (enExample)
CH (1) CH579395A5 (enExample)
DE (1) DE2109057A1 (enExample)
DK (1) DK128716B (enExample)
ES (1) ES388539A1 (enExample)
FR (1) FR2081544A1 (enExample)
NL (1) NL7102593A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413641A1 (de) * 1973-03-22 1974-10-03 Michel Fontaine Verfahren zur herstellung von medikamenten zur behandlung von neoplasen, infektionen, zur unspezifischen stimulierung der immunitaet sowie unterstuetzungsmittel bei der aktiven immuntherapie und bei impfungen sowie hieraus herstellbare medikamente

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2413641A1 (de) * 1973-03-22 1974-10-03 Michel Fontaine Verfahren zur herstellung von medikamenten zur behandlung von neoplasen, infektionen, zur unspezifischen stimulierung der immunitaet sowie unterstuetzungsmittel bei der aktiven immuntherapie und bei impfungen sowie hieraus herstellbare medikamente

Also Published As

Publication number Publication date
NL7102593A (enExample) 1971-08-31
BE763573A (fr) 1971-08-26
ES388539A1 (es) 1974-02-01
CA970279A (en) 1975-07-01
DE2109057A1 (de) 1971-09-09
FR2081544B1 (enExample) 1975-01-17
CH579395A5 (enExample) 1976-09-15
DK128716B (da) 1974-06-24

Similar Documents

Publication Publication Date Title
IT951686B (it) Sistema per assistere la circola zione del sangue
IT1041469B (it) Apparecchio per effettuare l operazione di plasmaferesi con separazione di globuli rossi del plasma contemporanea all estrazione del sangue del donatore
FR2285857A1 (fr) Agent de controle medical destine a etre administre par voie intravasculaire
CA1012023A (en) Device for the extraction of blood
ES398962A1 (es) Un procedimiento para la preparacion de una composicion de enzima.
AT353396B (de) Einrichtung zur kontrollierten selktiven ab- scheidung unerwuenschter bestandteile aus blut zur erzielung eines therapeutischen effektes
ZA72423B (en) Improvements in or relating to the treatment of diseases of the skin or mucosa
IT976125B (it) Procedimento e dispositivo per l estrazione del sangue dal corpo di animali abbattuti
Oostburg Thiabendazole therapy of Lagochilascaris minor infection in Surinam: report of a case
FR2081544A1 (en) Immuno-suppressive antilymphocytic serum and - and derived immunoglobulg
Santoro et al. Parasite ‘M’antigen in milk from mothers infected with Schistosoma mansoni (preliminary report)
CA950827A (en) Method of immunizing cattle against bovine respiratory disease syndrome
GB1355961A (en) Preparation of immunosuppressive antilymphocytic serum
FR2160285A1 (en) Embryonic serum-based compsn - used as a skin tonic
GB1167469A (en) Plasminogen Activator and Isolation Thereof
FR2189021A1 (en) Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues
GB1339737A (en) Diagnostic agents for primary hepatoma
SU59946A1 (ru) Способ получени противочумной сыворотки свиней
BE772666A (fr) Application de certaines diphenyl-sulfones au traitement de la maladie de marek
FR1281084A (fr) Procédé de préparation d'un cuir artificiel perméable à la vapeur d'eau et absorbant l'humidité et cuir conforme à celui obtenu
SU1162440A1 (ru) Способ лечени инфекционных осложнений у больных с ожогами
SU533102A1 (ru) Способ получения иммунной сыворотки
ES421324A1 (es) Procedimiento para la obtencion de preparados y extractos alergenicos.
SHI et al. Evaluation of safety and efficiency of treatment with autologous cytokine-induced killer cell for hepatocellular carcinoma
DU et al. Preliminary experiences on the treatment graft versus host disease after liver transplantation

Legal Events

Date Code Title Description
ST Notification of lapse